Sreeni Sivan Pillai: When Hemostasis Fails: How Coagulopathy Disrupts the Body’s Most Critical Safety System
Sreeni Sivan Pillai, Technical Incharge/Interventional and Endovascular Radiology Systems Strategist, Outcome Architect at Narayana Health, shared on LinkedIn:
“When Hemostasis Fails: How Coagulopathy Disrupts the Body’s Most Critical Safety System
Hemostasis is one of the most elegant protective mechanisms in human physiology—quiet, precise, and life-saving. Yet, when coagulopathy sets in, this system can collapse within minutes, turning simple procedures into high-risk events.
As clinicians, technicians, and interventionists, understanding how and where this breakdown happens is not just academic—it directly determines patient outcomes in the cath lab, hybrid OR, trauma bay and ICU.
The Real Problem: Coagulopathy Disrupts Hemostasis at Every Level
1. Primary Hemostasis – The Platelet Plug Fails
Coagulopathy can impair platelet function or reduce platelet numbers.
This leads to:
Poor adhesion and aggregation
Persistent oozing during vascular access
Fragile initial clot formation
Practical impact: Even a well-compressed access site may continue to bleed because the platelet foundation itself is weak.
2.Secondary Hemostasis – The Coagulation Cascade Stalls
Factor deficiency (Liver disease, DIC, dilutional coagulopathy, anticoagulation) disrupts the thrombin burst, resulting in:
Slow or incomplete fibrin formation
Difficulty achieving procedural hemostasis
Increased risk during sheath removal or post-angioplasty
Practical insight: When thrombin generation is inadequate, compression alone cannot stop bleeding—the clot simply has no structural strength.
3. Fibrin Stability – The Clot Is Built but Breaks Apart
Conditions like hyperfibrinolysis or Factor XIII deficiency cause early lysis of formed clots.
Clinical signals:
Recurrent bleeding after initial control
Hematoma formation despite normal platelets
Soft, unstable clot on visual assessment
Why it matters: A clot that dissolves too early is often mistaken for “technical bleeding,” when the true culprit is biochemical.
Dysregulated Anticoagulant Pathways – The Balance Tips Too Far
Excess activation of natural anticoagulants (Protein C/S, antithrombin, tPA) or iatrogenic anticoagulation suppresses thrombin generation.
Real-world risk:
Even low-intensity procedural manipulations can cause disproportionate bleeding.
Why This Matters in Daily Practice
In the vascular suite or cath lab, coagulopathy reveals itself subtly:
Persistent oozing at access sites
Difficulty securing hemostasis after sheath removal
Hematoma despite correct compression technique
Unexplained drop in hemoglobin
Abnormal TEG/ROTEM patterns that predict instability
Recognizing these clues early transforms outcomes.
Coagulopathy isn’t a single defect—it is a multilevel failure of hemostasis, disrupting:
Platelet plug formation
Coagulation factor activity
Fibrin stability
Regulatory balance
And when these systems fail, the stability of every procedure—from simple cannulation to complex endovascular work—is at risk”
More posts about Hemostasis on Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment